Morris Emma V, Edwards Claire M
Nuffield Department of Surgical Sciences, University of Oxford , Oxford , UK.
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Front Endocrinol (Lausanne). 2016 Jul 14;7:90. doi: 10.3389/fendo.2016.00090. eCollection 2016.
The bone marrow is a favored site for a number of cancers, including the hematological malignancy multiple myeloma, and metastasis of breast and prostate cancer. This specialized microenvironment is highly supportive, not only for tumor growth and survival but also for the development of an associated destructive cancer-induced bone disease. The interactions between tumor cells, osteoclasts and osteoblasts are well documented. By contrast, despite occupying a significant proportion of the bone marrow, the importance of bone marrow adipose tissue is only just emerging. The ability of bone marrow adipocytes to regulate skeletal biology and hematopoiesis, combined with their metabolic activity, endocrine functions, and proximity to tumor cells means that they are ideally placed to impact both tumor growth and bone disease. This review discusses the recent advances in our understanding of how marrow adipose tissue contributes to bone metastasis and cancer-induced bone disease.
骨髓是多种癌症的常见发生部位,包括血液系统恶性肿瘤多发性骨髓瘤以及乳腺癌和前列腺癌的转移。这种特殊的微环境不仅对肿瘤的生长和存活具有高度支持作用,而且对相关的具有破坏性的癌症诱导性骨病的发展也有促进作用。肿瘤细胞、破骨细胞和成骨细胞之间的相互作用已有充分记载。相比之下,尽管骨髓脂肪组织在骨髓中占相当大的比例,但其重要性才刚刚被认识到。骨髓脂肪细胞调节骨骼生物学和造血功能的能力,以及它们的代谢活性、内分泌功能和与肿瘤细胞的接近程度,意味着它们处于理想的位置来影响肿瘤生长和骨病。本综述讨论了我们在理解骨髓脂肪组织如何促进骨转移和癌症诱导性骨病方面的最新进展。